|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
FSH at a wide range of doses is routinely added to culture
media during in vitro maturation (IVM) of oocytes, but the
effects on oocyte health are unclear. The suggestion that
superovulation may cause aneuploidy and fetal
abnormalities prompted us to study the potential role of
FSH in the genesis of chromosomal abnormalities during
meiosis I. Mouse cumulus-oocyte complexes (COCs) isolated
from the antral follicles of unprimed, sexually immature
B6CBF1 mice were cultured in increasing concentrations of
FSH. Following culture, matured oocytes were isolated,
spread, stained with DAPI and the numbers of chromosomes
were counted. Significantly increased aneuploidy, arising
during the first meiotic division, was observed in
metaphase II oocytes matured in higher concentrations of
FSH (
20 ng/ml). The effect of FSH on spindle morphology
and chromosome alignment during metaphase I was then
explored using immunocytochemistry and three-dimensional
reconstruction of confocal sections. High FSH had no
effect on gross spindle morphology, but did alter
chromosome congression during prometaphase and metaphase,
with the spread of chromosomes across the spindle at this
time being significantly greater in oocytes cultured in
2000 ng/ml compared to 2 ng/ml FSH. Analysis of
three-dimensional reconstructions of spindles in oocytes
matured in 2000 ng/ml FSH shows that chromosomes are more
scattered and further apart than they are following
maturation in 2 ng/ml FSH. These results demonstrate that
exposure to high levels of FSH during in vitro maturation
can accelerate nuclear maturation and induce chromosomal
abnormalities, and highlights the importance of the
judicious use of FSH during in vitro maturation.
Key words:
Gamete Biology
Follicle-stimulating hormone
Meiosis
Oocyte development
This article has been cited by other articles:
![]() |
K. T. Jones Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age Hum. Reprod. Update, March 1, 2008; 14(2): 143 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Neganova, H. Al-Qassab, H. Heffron, C. Selman, A. I. Choudhury, S. J. Lingard, I. Diakonov, M. Patterson, M. Ghatei, S. R. Bloom, et al. Role of Central Nervous System and Ovarian Insulin Receptor Substrate 2 Signaling in Female Reproductive Function in the Mouse Biol Reprod, June 1, 2007; 76(6): 1045 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rossi, G. Macchiarelli, M.G. Palmerini, R. Canipari, and S. Cecconi Meiotic spindle configuration is differentially influenced by FSH and epidermal growth factor during in vitro maturation of mouse oocytes Hum. Reprod., July 1, 2006; 21(7): 1765 - 1770. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akiyama, M. Nagata, and F. Aoki Inadequate histone deacetylation during oocyte meiosis causes aneuploidy and embryo death in mice PNAS, May 9, 2006; 103(19): 7339 - 7344. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Kreeger, N. N. Fernandes, T. K. Woodruff, and L. D. Shea Regulation of Mouse Follicle Development by Follicle-Stimulating Hormone in a Three-Dimensional In Vitro Culture System Is Dependent on Follicle Stage and Dose Biol Reprod, November 1, 2005; 73(5): 942 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A Preis, G. Seidel Jr, and D. K Gardner Metabolic markers of developmental competence for in vitro-matured mouse oocytes Reproduction, October 1, 2005; 130(4): 475 - 483. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |